Treatment of hypertension during pregnancy

Introduction: Hypertension during pregnancy is one of the most frequent causes of maternal and fetal morbimortality. Perinatal and maternal death and disability rates have decreased by 30%, but hypertension during pregnancy has increased by approximately 10% in the last 30 years. This research aimed...

Descripción completa

Detalles Bibliográficos
Autores: Lestón Vázquez, Marta, Gomez-Lumbreras, Ainhoa|||0000-0002-3916-0402, Vilaplana-Carnerero, Carles|||0000-0003-3780-4996, Vedia Urgell, Cristina|||0000-0003-4192-3779, Morros, Rosa|||0000-0001-6752-8748, Giner-Soriano, Maria|||0000-0003-3750-9233
Tipo de recurso: artículo
Fecha de publicación:2024
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:312116
Acceso en línea:https://ddd.uab.cat/record/312116
https://dx.doi.org/urn:doi:10.3389/fphar.2024.1346357
Access Level:acceso abierto
Palabra clave:Hypertension
Pregnancy-induced
Pregnancy outcome
Antihypertensive agents
Cohort studies
Electronic health records
EHR
id ES_1faece038d456cdab27f4b7d64c1d42d
oai_identifier_str oai:ddd.uab.cat:312116
network_acronym_str ES
network_name_str España
repository_id_str
spelling Treatment of hypertension during pregnancya cohort of pregnancy episodes from the SIDIAP database, Catalonia, SpainLestón Vázquez, MartaGomez-Lumbreras, Ainhoa|||0000-0002-3916-0402Vilaplana-Carnerero, Carles|||0000-0003-3780-4996Vedia Urgell, Cristina|||0000-0003-4192-3779Morros, Rosa|||0000-0001-6752-8748Giner-Soriano, Maria|||0000-0003-3750-9233HypertensionPregnancy-inducedPregnancy outcomeAntihypertensive agentsCohort studiesElectronic health recordsEHRIntroduction: Hypertension during pregnancy is one of the most frequent causes of maternal and fetal morbimortality. Perinatal and maternal death and disability rates have decreased by 30%, but hypertension during pregnancy has increased by approximately 10% in the last 30 years. This research aimed to describe the pharmacological treatment and pregnancy outcomes of pregnancies with hypertension. Methods: We carried out an observational cohort study from the Information System for the Development of Research in Primary Care (SIDIAP) database. Pregnancy episodes with hypertension (ICD-10 codes for hypertension, I10-I15 and O10-O16) were identified. Antihypertensives were classified according to the ATC WHO classification: β-blocking agents (BBs), calcium channel blockers (CCBs), agents acting on the renin-angiotensin system (RAS agents), diuretics, and antiadrenergic agents. Exposure was defined for hypertension in pregnancies with ≥2 prescriptions during the pregnancy episode. Descriptive statistics for diagnoses and treatments were calculated. Results: In total, 4,839 pregnancies with hypertension diagnosis formed the study cohort. There were 1,944 (40.2%) pregnancies exposed to an antihypertensive medication. There were differences in mother's age, BMI, and alcohol intake between pregnancies exposed to antihypertensive medications and those not exposed. BBs were the most used (n = 1,160 pregnancy episodes; 59.7%), followed by RAS agents (n = 825, 42.4%), and CCBs were the least used (n = 347, 17.8%). Discussion: Pregnancies involving hypertension were exposed to antihypertensive medications, mostly BBs. We conduct a study focused on RAS agent use during pregnancy and its outcomes in the offspring. 22024-01-0120242024-01-01Articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttps://ddd.uab.cat/record/312116https://dx.doi.org/urn:doi:10.3389/fphar.2024.1346357reponame:Dipòsit Digital de Documents de la UABinstname:Universitat Autònoma de BarcelonaInglésengopen accesshttp://purl.org/coar/access_right/c_abf2Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.https://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:ddd.uab.cat:3121162026-06-06T12:50:31Z
dc.title.none.fl_str_mv Treatment of hypertension during pregnancy
a cohort of pregnancy episodes from the SIDIAP database, Catalonia, Spain
title Treatment of hypertension during pregnancy
spellingShingle Treatment of hypertension during pregnancy
Lestón Vázquez, Marta
Hypertension
Pregnancy-induced
Pregnancy outcome
Antihypertensive agents
Cohort studies
Electronic health records
EHR
title_short Treatment of hypertension during pregnancy
title_full Treatment of hypertension during pregnancy
title_fullStr Treatment of hypertension during pregnancy
title_full_unstemmed Treatment of hypertension during pregnancy
title_sort Treatment of hypertension during pregnancy
dc.creator.none.fl_str_mv Lestón Vázquez, Marta
Gomez-Lumbreras, Ainhoa|||0000-0002-3916-0402
Vilaplana-Carnerero, Carles|||0000-0003-3780-4996
Vedia Urgell, Cristina|||0000-0003-4192-3779
Morros, Rosa|||0000-0001-6752-8748
Giner-Soriano, Maria|||0000-0003-3750-9233
author Lestón Vázquez, Marta
author_facet Lestón Vázquez, Marta
Gomez-Lumbreras, Ainhoa|||0000-0002-3916-0402
Vilaplana-Carnerero, Carles|||0000-0003-3780-4996
Vedia Urgell, Cristina|||0000-0003-4192-3779
Morros, Rosa|||0000-0001-6752-8748
Giner-Soriano, Maria|||0000-0003-3750-9233
author_role author
author2 Gomez-Lumbreras, Ainhoa|||0000-0002-3916-0402
Vilaplana-Carnerero, Carles|||0000-0003-3780-4996
Vedia Urgell, Cristina|||0000-0003-4192-3779
Morros, Rosa|||0000-0001-6752-8748
Giner-Soriano, Maria|||0000-0003-3750-9233
author2_role author
author
author
author
author
dc.subject.none.fl_str_mv Hypertension
Pregnancy-induced
Pregnancy outcome
Antihypertensive agents
Cohort studies
Electronic health records
EHR
topic Hypertension
Pregnancy-induced
Pregnancy outcome
Antihypertensive agents
Cohort studies
Electronic health records
EHR
description Introduction: Hypertension during pregnancy is one of the most frequent causes of maternal and fetal morbimortality. Perinatal and maternal death and disability rates have decreased by 30%, but hypertension during pregnancy has increased by approximately 10% in the last 30 years. This research aimed to describe the pharmacological treatment and pregnancy outcomes of pregnancies with hypertension. Methods: We carried out an observational cohort study from the Information System for the Development of Research in Primary Care (SIDIAP) database. Pregnancy episodes with hypertension (ICD-10 codes for hypertension, I10-I15 and O10-O16) were identified. Antihypertensives were classified according to the ATC WHO classification: β-blocking agents (BBs), calcium channel blockers (CCBs), agents acting on the renin-angiotensin system (RAS agents), diuretics, and antiadrenergic agents. Exposure was defined for hypertension in pregnancies with ≥2 prescriptions during the pregnancy episode. Descriptive statistics for diagnoses and treatments were calculated. Results: In total, 4,839 pregnancies with hypertension diagnosis formed the study cohort. There were 1,944 (40.2%) pregnancies exposed to an antihypertensive medication. There were differences in mother's age, BMI, and alcohol intake between pregnancies exposed to antihypertensive medications and those not exposed. BBs were the most used (n = 1,160 pregnancy episodes; 59.7%), followed by RAS agents (n = 825, 42.4%), and CCBs were the least used (n = 347, 17.8%). Discussion: Pregnancies involving hypertension were exposed to antihypertensive medications, mostly BBs. We conduct a study focused on RAS agent use during pregnancy and its outcomes in the offspring.
publishDate 2024
dc.date.none.fl_str_mv 2
2024-01-01
2024
2024-01-01
dc.type.none.fl_str_mv Article
http://purl.org/coar/resource_type/c_6501
VoR
http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://ddd.uab.cat/record/312116
https://dx.doi.org/urn:doi:10.3389/fphar.2024.1346357
url https://ddd.uab.cat/record/312116
https://dx.doi.org/urn:doi:10.3389/fphar.2024.1346357
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by/4.0/
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Dipòsit Digital de Documents de la UAB
instname:Universitat Autònoma de Barcelona
instname_str Universitat Autònoma de Barcelona
reponame_str Dipòsit Digital de Documents de la UAB
collection Dipòsit Digital de Documents de la UAB
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869404415033606144
score 15.812429